INTERNATIONAL PATENT: KRKA, D.D., NOVO MESTO FILES APPLICATION FOR "BILAYER TABLET FORMULATION COMPRISING DAPAGLIFLOZIN AND METFORMIN"

GENEVA, July 1 -- KRKA, D.D., NOVO MESTO (Smarjeska cesta 68501 NOVO MESTO) filed a patent application (PCT/EP2024/087571) for "Bilayer tablet formulation comprising dapagliflozin and metformin" on Dec 19, 2024. With publication no. WO/2025/132901, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MIRTIČ, Janja (c/o KRKA, d.d., Novo mestoSmarjeska cesta 68501 NOVO MESTO), KONDA, Tanja (c/o KRKA, d.d., Novo mestoSmarjeska cesta 68501 NOVO MESTO), DOBROVOLJC, Katarina (c/o KRKA, d.d., Novo mestoSmarjeska cesta 68501 NOVO...